These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 3038391

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62. Evaluation of angiotensin converting enzyme (ACE) in the pharmacokinetics and pharmacodynamics of ACE inhibitors.
    Johnston CI, Jackson B, Cubela R, Larmour I, Arnolda L.
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S9-14. PubMed ID: 2422495
    [Abstract] [Full Text] [Related]

  • 63. Acute hemodynamic and hormonal effects of lisinopril (MK-521) in congestive heart failure.
    Dickstein K, Aarsland T, Woie L, Abrahamsen AM, Fyhrquist F, Cummings S, Gomex HJ, Hagen E, Kristianson K.
    Am Heart J; 1986 Jul; 112(1):121-9. PubMed ID: 3014850
    [Abstract] [Full Text] [Related]

  • 64. Angiotensin-converting enzyme responses following enalapril in the sodium deficient rat.
    Longman SD, Howlett DR.
    Eur J Pharmacol; 1986 Apr 29; 123(3):379-86. PubMed ID: 3013653
    [Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66. Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts.
    Schunkert H, Jackson B, Tang SS, Schoen FJ, Smits JF, Apstein CS, Lorell BH.
    Circulation; 1993 Apr 29; 87(4):1328-39. PubMed ID: 8384939
    [Abstract] [Full Text] [Related]

  • 67. Exclusion of angiotensin I-converting enzyme as a candidate gene involved in exudative inflammatory resistance in F344/N rats.
    Jafarian-Tehrani M, Listwak S, Barrientos RM, Michaud A, Corvol P, Sternberg EM.
    Mol Med; 2000 Apr 29; 6(4):319-31. PubMed ID: 10949912
    [Abstract] [Full Text] [Related]

  • 68. Comparative studies of tissue inhibition by angiotensin converting enzyme inhibitors.
    Johnston CI, Fabris B, Yamada H, Mendelsohn FA, Cubela R, Sivell D, Jackson B.
    J Hypertens Suppl; 1989 Sep 29; 7(5):S11-6. PubMed ID: 2553899
    [Abstract] [Full Text] [Related]

  • 69. In-vitro and in-vivo inhibition of rat neutral endopeptidase and angiotensin converting enzyme with the vasopeptidase inhibitor gemopatrilat.
    Hubner RA, Kubota E, Casley DJ, Johnston CI, Burrell LM.
    J Hypertens; 2001 May 29; 19(5):941-6. PubMed ID: 11393678
    [Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74. Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response?
    van den Meiracker AH, Man in 't Veld AJ, Admiraal PJ, Ritsema van Eck HJ, Boomsma F, Derkx FH, Schalekamp MA.
    J Hypertens; 1992 Aug 29; 10(8):803-12. PubMed ID: 1325513
    [Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80. Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure.
    O'Toole L, Stewart M, Padfield P, Channer K.
    J Cardiovasc Pharmacol; 1998 Dec 29; 32(6):988-94. PubMed ID: 9869506
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.